文献检索文档翻译深度研究
Suppr Zotero 插件Zotero 插件
邀请有礼套餐&价格历史记录

新学期，新优惠

限时优惠:9月1日-9月22日

30天高级会员仅需29元

1天体验卡首发特惠仅需5.99元

了解详情
不再提醒
插件&应用
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
高级版
套餐订阅购买积分包
AI 工具
文献检索文档翻译深度研究
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2025

India's syndemic of tuberculosis and COVID-19.

作者信息

Shrinivasan Rukmini, Rane Saurabh, Pai Madhukar

机构信息

Independent Data Journalist, Chennai, India.

Survivors Against Tuberculosis, Mumbai, India.

出版信息

BMJ Glob Health. 2020 Nov;5(11). doi: 10.1136/bmjgh-2020-003979.

DOI:10.1136/bmjgh-2020-003979
PMID:33199280
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7670552/
Abstract
摘要
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6e1e/7670552/423baf4c70c4/bmjgh-2020-003979f04.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6e1e/7670552/778573fa01b0/bmjgh-2020-003979f01.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6e1e/7670552/dd19c6427bf3/bmjgh-2020-003979f02.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6e1e/7670552/1d755167df21/bmjgh-2020-003979f03.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6e1e/7670552/423baf4c70c4/bmjgh-2020-003979f04.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6e1e/7670552/778573fa01b0/bmjgh-2020-003979f01.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6e1e/7670552/dd19c6427bf3/bmjgh-2020-003979f02.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6e1e/7670552/1d755167df21/bmjgh-2020-003979f03.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6e1e/7670552/423baf4c70c4/bmjgh-2020-003979f04.jpg

相似文献

[1]
India's syndemic of tuberculosis and COVID-19.

BMJ Glob Health. 2020-11

[2]
The COVID-19/Tuberculosis Syndemic and Potential Antibody Therapy for TB Based on the Lessons Learnt From the Pandemic.

Front Immunol. 2022

[3]
Tuberculosis patients not covered by treatment in public health services: findings from India's National Family Health Survey 2015-16.

Trop Med Int Health. 2018-6-25

[4]
EXPERIENCING SYNDEMIC: DISENTANGLING THE BIOSOCIAL COMPLEXITY OF TUBERCULOSIS THROUGH QUALITATIVE RESEARCH.

J Biosoc Sci. 2019-5

[5]
Ending the tuberculosis syndemic: is COVID-19 the (in)convenient scapegoat for poor progress?

Lancet Respir Med. 2022-6

[6]
India's pain: beyond COVID-19 case numbers and mortality rates.

Lancet. 2021-6-26

[7]
Dismal global tuberculosis situation due to COVID-19.

Lancet Infect Dis. 2021-12

[8]
COVID-19 and syndemic challenges in 'Battling the Big Three': HIV, TB and malaria.

Int J Infect Dis. 2021-5

[9]
Tuberculosis management in India during COVID-19 crisis.

J Public Health Policy. 2021-3

[10]
India's private sector needs to take greater role in tuberculosis care.

BMJ. 2016-9-2

引用本文的文献

[1]
Impact of the COVID-19 Pandemic on Tuberculosis: A Retrospective Analytical Study of Morbidity Profiles, Trends, and Patient Care in a Primary Tuberculosis Treatment Unit in India.

Cureus. 2025-4-9

[2]
Impact of the COVID-19 pandemic on the epidemiology and clinical course of tuberculosis: expected and paradoxical consequences.

BMC Infect Dis. 2025-3-26

[3]
The long-term impact of the COVID-19 pandemic on tuberculosis care and infection control measures in anti-retroviral therapy (ART) clinics in low- and middle-income countries: a multiregional site survey in Asia and Africa.

BMJ Glob Health. 2025-3-24

[4]
Impact of COVID-19 pandemic on tuberculosis notification and outcome in a district of South Gujarat.

J Family Med Prim Care. 2024-11

[5]
Case fatality among people with drug-susceptible TB enrolled in a private health sector TB treatment support program in Bihar, India during the first year of the COVID-19 pandemic.

PLOS Glob Public Health. 2024-9-12

[6]
Assessing the impact of COVID-19 management on the workload of human resources working in India's National Tuberculosis Elimination Program.

BMC Health Serv Res. 2024-8-7

[7]
The global impact of COVID-19 on tuberculosis: A thematic scoping review, 2020-2023.

PLOS Glob Public Health. 2024-7-3

[8]
A Descriptive Study on the Clinical Profile and Outcomes of Patients with COVID-19 and Tuberculosis Co-infection.

Acta Med Philipp. 2024-5-15

[9]
Is Pollution the Primary Driver of Infectious Syndemics?

Pathogens. 2024-4-30

[10]
Triple Burden: The Incorrigible Threat of Tuberculosis, HIV, and COVID-19.

Infect Disord Drug Targets. 2024

本文引用的文献

[1]
The potential impact of the COVID-19 response related lockdown on TB incidence and mortality in India.

Indian J Tuberc. 2020-12

[2]
Social determinants of tuberculosis: context, framework, and the way forward to ending TB in India.

Expert Rev Respir Med. 2021-7

[3]
Understanding why at-risk population segments do not seek care for tuberculosis: a precision public health approach in South India.

BMJ Glob Health. 2020-9

[4]
Covid-19 exposes the high cost of India's reliance on private healthcare.

BMJ. 2020-9-10

[5]
Is India missing COVID-19 deaths?

Lancet. 2020-9-5

[6]
Quality of tuberculosis care in the private health sector.

J Clin Tuberc Other Mycobact Dis. 2020-6-13

[7]
Missing men with tuberculosis: the need to address structural influences and implement targeted and multidimensional interventions.

BMJ Glob Health. 2020-5

[8]
Tuberculosis case fatality in India: a systematic review and meta-analysis.

BMJ Glob Health. 2020

[9]
Digital adherence technologies for the management of tuberculosis therapy: mapping the landscape and research priorities.

BMJ Glob Health. 2018-10-11

[10]
Variations in the quality of tuberculosis care in urban India: A cross-sectional, standardized patient study in two cities.

PLoS Med. 2018-9-25

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

推荐工具

医学文档翻译智能文献检索